Novel Medical Treatments for Hypertension and Related Comorbidities
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://link.springer.com/article/10.1007/s11906-018-0890-y/fulltext.html
Reference106 articles.
1. Saklayen MG, Deshpande NV. Timeline of history of hypertension treatment. Front Cardiovasc Med. 2016;3:3. https://doi.org/10.3389/fcvm.2016.00003 .
2. Administration USDoHaHSFaD. Approved drug products with therapeutic equivalence evaluations (orange book). 38 ed. 2018.
3. •• Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116(6):1074–95. https://doi.org/10.1161/CIRCRESAHA.116.303603 . This comprehensive review of novel hypertension treatments published in 2015 serves as the basis for our paper outlining updates of these novel treatments.
4. •• Group SR, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of Intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16. https://doi.org/10.1056/NEJMoa1511939 . The SPRINT trial has provided important new evidence to inform the most recent hypertension guidelines, which recommend lower BP goals in hypertensive patients.
5. •• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017; https://doi.org/10.1161/HYP.0000000000000066 . The most recent hypertension guidelines in the US which has lowered the target for BP treatment and has lowered the BP threshold for the diagnosis of hypertension.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent Insights on Drug Delivery System in Hypertension: From Bench to Market;Current Hypertension Reviews;2023-08
2. Therapeutics for Substance-Using Women: The Need to Elucidate Sex-Specific Targets for Better-Tailored Treatments;Sex and Gender Effects in Pharmacology;2023
3. Renin–angiotensin–aldosterone system inhibitors. New and old approaches;Angiotensin;2023
4. In Vitro Dissolution Profile of Antihypertensive Mixture: Comparison Between Multivariate Methods and Statistical and Graphical Representation of Different Univariate Spectrophotometric Data;Journal of AOAC International;2022-11-24
5. Combinatorial approaches for novel cardiovascular drug discovery: a review of the literature;Expert Opinion on Drug Discovery;2022-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3